Importantly, CALR exon 9 mutations were suggested to be early initiating events in MPN, and more recently mutant CALR (mCALR) has been shown to mediate thrombopoietin-independent activation of the thrombopoietin receptor MPL [9, 10]. This evidence concerns the gene CALR and myeloproliferative neoplasm.